{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_1927"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_1927","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Endothelin-1-induced calcium signaling in arteries and veins","abstract":"Due to the high volume of blood contained in the venous circulation, a small increase in venous contraction can have a profound impact on systemic blood distribution and blood pressure. The endogenous vasoconstrictor peptide Endothelin-1 (ET-1) has been identified as a regulator of venous tone, since veins desensitize less than arteries to ET-1 and maintain contractility to ET-1 in hypertension. However, relatively little is known about the mechanisms regulating venous contraction. This project was designed to explore how increases in intracellular Ca<super>2+</super> relate to venous contractility, and test the hypothesis that Ca<super>2+</super> signaling induced by ET-1 differs between veins and arteries. Although contraction to ET-1 in rat aorta (RA) and rat vena cava (RVC) requires Ca<super>2+</super>, inhibition of voltage-gated calcium channels or nonselective cation channels did not significantly inhibit ET-1-induced contraction in either tissue. However, inhibition of the reverse-mode Na<super>+</super>/Ca<super>2+</super> exchanger (NCX) by KB-R7943 (10 &mu;M) significantly attenuated ET-1-induced contraction in RVC but not RA, suggesting that calcium influx by reverse-mode NCX is an important mechanism of Ca<super>2+</super> influx during ET-1-induced contraction of RVC (chapter 3). We next investigated the mechanisms of intracellular Ca<super>2+</super> stores release activated by ET-1 by examining the presence and function of ryanodine receptors (RyR) (chapter 4) and IP<sub>3</sub> receptors (IP<sub>3</sub>R) (chapter 5) in RA and RVC. RA expressed mRNA for all 3 RyR subtypes, and the RyR activator caffeine (20 mM) caused a prolonged increase in intracellular Ca<super>2+</super> associated with a rapid contraction. While RVC also expressed RyR mRNA, caffeine caused a small, transient increase in intracellular Ca<super>2+</super> that was not associated with contraction. These data suggest that RyR, while present in both RA and RVC, are unable to release sufficient Ca<super>2+</super> to cause contraction in RVC. RA and RVC express protein for all 3 IP<sub>3</sub>R subtypes, and the membrane-permeable IP<sub>3</sub> analogue, Bt-IP<sub>3</sub>, caused contraction in both tissues. To measure ET-1-induced IP<sub>3</sub>R activation, Ca<super>2+</super> wave characteristics were measured in RVC during exposure to ET-1 (100 nM). ET-1 increased Ca<super>2+</super> wave frequency, occurrence and velocity in RVC, suggesting IP<sub>3</sub>-mediated Ca<super>2+</super> release. However, ET-1-induced contraction was unchanged by the IP<sub>3</sub>R inhibitor 2-APB (100 &mu;M), suggesting IP<sub>3</sub>-mediated Ca<super>2+</super> release was not a significant source of Ca<super>2+</super> during RVC contraction. To test if phospholipase-C (PLC) was activated by ET-1, isometric contraction was measured in RA and RVC rings exposed to vehicle, the PLC inhibitor U-73122 or its inactive analog U-73343 (1 &mu;M). While U-73343 did not significantly inhibit contraction to ET-1, U-73122 significantly reduced maximum contraction to ET-1 in both tissues. These findings suggest that ET-1 activates PLC in RA and RVC, but DAG - and not IP<sub>3</sub> - may regulate contraction to ET-1 in RVC.Taken together, these findings suggest that mechanisms of both extracellular Ca<super>2+</super> influx and intracellular Ca<super>2+</super> release are different in RVC than in RA, and that this may account for the differences in ET-1-induced contraction between RA and RVC.","abstract_html":"Due to the high volume of blood contained in the venous circulation, a small increase in venous contraction can have a profound impact on systemic blood distribution and blood pressure. The endogenous vasoconstrictor peptide Endothelin-1 (ET-1) has been identified as a regulator of venous tone, since veins desensitize less than arteries to ET-1 and maintain contractility to ET-1 in hypertension. However, relatively little is known about the mechanisms regulating venous contraction. This project was designed to explore how increases in intracellular Ca&lt;super&gt;2+&lt;/super&gt; relate to venous contractility, and test the hypothesis that Ca&lt;super&gt;2+&lt;/super&gt; signaling induced by ET-1 differs between veins and arteries. Although contraction to ET-1 in rat aorta (RA) and rat vena cava (RVC) requires Ca&lt;super&gt;2+&lt;/super&gt;, inhibition of voltage-gated calcium channels or nonselective cation channels did not significantly inhibit ET-1-induced contraction in either tissue. However, inhibition of the reverse-mode Na&lt;super&gt;+&lt;/super&gt;/Ca&lt;super&gt;2+&lt;/super&gt; exchanger (NCX) by KB-R7943 (10 &amp;mu;M) significantly attenuated ET-1-induced contraction in RVC but not RA, suggesting that calcium influx by reverse-mode NCX is an important mechanism of Ca&lt;super&gt;2+&lt;/super&gt; influx during ET-1-induced contraction of RVC (chapter 3). We next investigated the mechanisms of intracellular Ca&lt;super&gt;2+&lt;/super&gt; stores release activated by ET-1 by examining the presence and function of ryanodine receptors (RyR) (chapter 4) and IP&lt;sub&gt;3&lt;/sub&gt; receptors (IP&lt;sub&gt;3&lt;/sub&gt;R) (chapter 5) in RA and RVC. RA expressed mRNA for all 3 RyR subtypes, and the RyR activator caffeine (20 mM) caused a prolonged increase in intracellular Ca&lt;super&gt;2+&lt;/super&gt; associated with a rapid contraction. While RVC also expressed RyR mRNA, caffeine caused a small, transient increase in intracellular Ca&lt;super&gt;2+&lt;/super&gt; that was not associated with contraction. These data suggest that RyR, while present in both RA and RVC, are unable to release sufficient Ca&lt;super&gt;2+&lt;/super&gt; to cause contraction in RVC. RA and RVC express protein for all 3 IP&lt;sub&gt;3&lt;/sub&gt;R subtypes, and the membrane-permeable IP&lt;sub&gt;3&lt;/sub&gt; analogue, Bt-IP&lt;sub&gt;3&lt;/sub&gt;, caused contraction in both tissues. To measure ET-1-induced IP&lt;sub&gt;3&lt;/sub&gt;R activation, Ca&lt;super&gt;2+&lt;/super&gt; wave characteristics were measured in RVC during exposure to ET-1 (100 nM). ET-1 increased Ca&lt;super&gt;2+&lt;/super&gt; wave frequency, occurrence and velocity in RVC, suggesting IP&lt;sub&gt;3&lt;/sub&gt;-mediated Ca&lt;super&gt;2+&lt;/super&gt; release. However, ET-1-induced contraction was unchanged by the IP&lt;sub&gt;3&lt;/sub&gt;R inhibitor 2-APB (100 &amp;mu;M), suggesting IP&lt;sub&gt;3&lt;/sub&gt;-mediated Ca&lt;super&gt;2+&lt;/super&gt; release was not a significant source of Ca&lt;super&gt;2+&lt;/super&gt; during RVC contraction. To test if phospholipase-C (PLC) was activated by ET-1, isometric contraction was measured in RA and RVC rings exposed to vehicle, the PLC inhibitor U-73122 or its inactive analog U-73343 (1 &amp;mu;M). While U-73343 did not significantly inhibit contraction to ET-1, U-73122 significantly reduced maximum contraction to ET-1 in both tissues. These findings suggest that ET-1 activates PLC in RA and RVC, but DAG - and not IP&lt;sub&gt;3&lt;/sub&gt; - may regulate contraction to ET-1 in RVC.Taken together, these findings suggest that mechanisms of both extracellular Ca&lt;super&gt;2+&lt;/super&gt; influx and intracellular Ca&lt;super&gt;2+&lt;/super&gt; release are different in RVC than in RA, and that this may account for the differences in ET-1-induced contraction between RA and RVC.","abstract_has_math":false,"creators":["Tykocki, Nathan R."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Watts, Stephanie W.","Jackson, William F.","Fink, Gregory D.","Galligan, James J.","Wiseman, Robert W."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012","date_published":"2012","updated_at":"2026-11-18T17:43:01Z","subjects":["Vascular endothelium","Intracellular calcium","Venous pressure","Research"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:1927","isbn:9781267565419","isbn:1267565411","oclc:931869133","umi:3523529","local:Tykocki_grad.msu_0128D_11414"],"render_values":[{"text":"etd:1927","href":null,"code":true},{"text":"isbn:9781267565419","href":null,"code":true},{"text":"isbn:1267565411","href":null,"code":true},{"text":"oclc:931869133","href":null,"code":true},{"text":"umi:3523529","href":null,"code":true},{"text":"local:Tykocki_grad.msu_0128D_11414","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/hh4z-9529","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/hh4z-9529","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_1927","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Watts, Stephanie W.","Jackson, William F.","Fink, Gregory D.","Galligan, James J.","Wiseman, Robert W."]},{"key":"dc:creator","label":"Author","values":["Tykocki, Nathan R."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2012"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Vascular endothelium","Intracellular calcium","Venous pressure","Research"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:1927","isbn:9781267565419","isbn:1267565411","oclc:931869133","umi:3523529","local:Tykocki_grad.msu_0128D_11414","https://doi.org/doi:10.25335/hh4z-9529"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Due to the high volume of blood contained in the venous circulation, a small increase in venous contraction can have a profound impact on systemic blood distribution and blood pressure. The endogenous vasoconstrictor peptide Endothelin-1 (ET-1) has been identified as a regulator of venous tone, since veins desensitize less than arteries to ET-1 and maintain contractility to ET-1 in hypertension. However, relatively little is known about the mechanisms regulating venous contraction. This project was designed to explore how increases in intracellular Ca<super>2+</super> relate to venous contractility, and test the hypothesis that Ca<super>2+</super> signaling induced by ET-1 differs between veins and arteries. Although contraction to ET-1 in rat aorta (RA) and rat vena cava (RVC) requires Ca<super>2+</super>, inhibition of voltage-gated calcium channels or nonselective cation channels did not significantly inhibit ET-1-induced contraction in either tissue. However, inhibition of the reverse-mode Na<super>+</super>/Ca<super>2+</super> exchanger (NCX) by KB-R7943 (10 &mu;M) significantly attenuated ET-1-induced contraction in RVC but not RA, suggesting that calcium influx by reverse-mode NCX is an important mechanism of Ca<super>2+</super> influx during ET-1-induced contraction of RVC (chapter 3). We next investigated the mechanisms of intracellular Ca<super>2+</super> stores release activated by ET-1 by examining the presence and function of ryanodine receptors (RyR) (chapter 4) and IP<sub>3</sub> receptors (IP<sub>3</sub>R) (chapter 5) in RA and RVC. RA expressed mRNA for all 3 RyR subtypes, and the RyR activator caffeine (20 mM) caused a prolonged increase in intracellular Ca<super>2+</super> associated with a rapid contraction. While RVC also expressed RyR mRNA, caffeine caused a small, transient increase in intracellular Ca<super>2+</super> that was not associated with contraction. These data suggest that RyR, while present in both RA and RVC, are unable to release sufficient Ca<super>2+</super> to cause contraction in RVC. RA and RVC express protein for all 3 IP<sub>3</sub>R subtypes, and the membrane-permeable IP<sub>3</sub> analogue, Bt-IP<sub>3</sub>, caused contraction in both tissues. To measure ET-1-induced IP<sub>3</sub>R activation, Ca<super>2+</super> wave characteristics were measured in RVC during exposure to ET-1 (100 nM). ET-1 increased Ca<super>2+</super> wave frequency, occurrence and velocity in RVC, suggesting IP<sub>3</sub>-mediated Ca<super>2+</super> release. However, ET-1-induced contraction was unchanged by the IP<sub>3</sub>R inhibitor 2-APB (100 &mu;M), suggesting IP<sub>3</sub>-mediated Ca<super>2+</super> release was not a significant source of Ca<super>2+</super> during RVC contraction. To test if phospholipase-C (PLC) was activated by ET-1, isometric contraction was measured in RA and RVC rings exposed to vehicle, the PLC inhibitor U-73122 or its inactive analog U-73343 (1 &mu;M). While U-73343 did not significantly inhibit contraction to ET-1, U-73122 significantly reduced maximum contraction to ET-1 in both tissues. These findings suggest that ET-1 activates PLC in RA and RVC, but DAG - and not IP<sub>3</sub> - may regulate contraction to ET-1 in RVC.Taken together, these findings suggest that mechanisms of both extracellular Ca<super>2+</super> influx and intracellular Ca<super>2+</super> release are different in RVC than in RA, and that this may account for the differences in ET-1-induced contraction between RA and RVC.","Thesis (Ph. D.)--Michigan State University. Pharmacology and Toxicology, 2012","Includes bibliographical references (pages 182-209)"]},{"key":"dc:format","label":"Dc Format","values":["xv, 209 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["Endothelin-1-induced calcium signaling in arteries and veins"]}]}],"canonical_facts":{"dc:contributor":["Watts, Stephanie W.","Jackson, William F.","Fink, Gregory D.","Galligan, James J.","Wiseman, Robert W."],"dc:creator":["Tykocki, Nathan R."],"dc:date":["2012"],"dc:description":["Due to the high volume of blood contained in the venous circulation, a small increase in venous contraction can have a profound impact on systemic blood distribution and blood pressure. The endogenous vasoconstrictor peptide Endothelin-1 (ET-1) has been identified as a regulator of venous tone, since veins desensitize less than arteries to ET-1 and maintain contractility to ET-1 in hypertension. However, relatively little is known about the mechanisms regulating venous contraction. This project was designed to explore how increases in intracellular Ca<super>2+</super> relate to venous contractility, and test the hypothesis that Ca<super>2+</super> signaling induced by ET-1 differs between veins and arteries. Although contraction to ET-1 in rat aorta (RA) and rat vena cava (RVC) requires Ca<super>2+</super>, inhibition of voltage-gated calcium channels or nonselective cation channels did not significantly inhibit ET-1-induced contraction in either tissue. However, inhibition of the reverse-mode Na<super>+</super>/Ca<super>2+</super> exchanger (NCX) by KB-R7943 (10 &mu;M) significantly attenuated ET-1-induced contraction in RVC but not RA, suggesting that calcium influx by reverse-mode NCX is an important mechanism of Ca<super>2+</super> influx during ET-1-induced contraction of RVC (chapter 3). We next investigated the mechanisms of intracellular Ca<super>2+</super> stores release activated by ET-1 by examining the presence and function of ryanodine receptors (RyR) (chapter 4) and IP<sub>3</sub> receptors (IP<sub>3</sub>R) (chapter 5) in RA and RVC. RA expressed mRNA for all 3 RyR subtypes, and the RyR activator caffeine (20 mM) caused a prolonged increase in intracellular Ca<super>2+</super> associated with a rapid contraction. While RVC also expressed RyR mRNA, caffeine caused a small, transient increase in intracellular Ca<super>2+</super> that was not associated with contraction. These data suggest that RyR, while present in both RA and RVC, are unable to release sufficient Ca<super>2+</super> to cause contraction in RVC. RA and RVC express protein for all 3 IP<sub>3</sub>R subtypes, and the membrane-permeable IP<sub>3</sub> analogue, Bt-IP<sub>3</sub>, caused contraction in both tissues. To measure ET-1-induced IP<sub>3</sub>R activation, Ca<super>2+</super> wave characteristics were measured in RVC during exposure to ET-1 (100 nM). ET-1 increased Ca<super>2+</super> wave frequency, occurrence and velocity in RVC, suggesting IP<sub>3</sub>-mediated Ca<super>2+</super> release. However, ET-1-induced contraction was unchanged by the IP<sub>3</sub>R inhibitor 2-APB (100 &mu;M), suggesting IP<sub>3</sub>-mediated Ca<super>2+</super> release was not a significant source of Ca<super>2+</super> during RVC contraction. To test if phospholipase-C (PLC) was activated by ET-1, isometric contraction was measured in RA and RVC rings exposed to vehicle, the PLC inhibitor U-73122 or its inactive analog U-73343 (1 &mu;M). While U-73343 did not significantly inhibit contraction to ET-1, U-73122 significantly reduced maximum contraction to ET-1 in both tissues. These findings suggest that ET-1 activates PLC in RA and RVC, but DAG - and not IP<sub>3</sub> - may regulate contraction to ET-1 in RVC.Taken together, these findings suggest that mechanisms of both extracellular Ca<super>2+</super> influx and intracellular Ca<super>2+</super> release are different in RVC than in RA, and that this may account for the differences in ET-1-induced contraction between RA and RVC.","Thesis (Ph. D.)--Michigan State University. Pharmacology and Toxicology, 2012","Includes bibliographical references (pages 182-209)"],"dc:format":["xv, 209 pages","application/pdf"],"dc:identifier":["etd:1927","isbn:9781267565419","isbn:1267565411","oclc:931869133","umi:3523529","local:Tykocki_grad.msu_0128D_11414","https://doi.org/doi:10.25335/hh4z-9529"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Vascular endothelium","Intracellular calcium","Venous pressure","Research"],"dc:title":["Endothelin-1-induced calcium signaling in arteries and veins"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T17:43:01Z"}